ArticleJournal of industrial microbiology & biotechnology2024
Characterization of S-glycosylated glycocins containing three disulfides.
Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Glycocins are a growing family of ribosomally synthesized and posttranslationally modified peptides (RiPPs) that are O- and/or S-glycosylated. Using a sequence similarity network of putative glycosyltransferases, the thg biosynthetic gene cluster (BGC) was identified in the genome of Thermoanaerobacterium thermosaccharolyticum. Heterologous expression in Escherichia coli showed that the glycosyltransferase (ThgS) encoded in the BGC adds N-acetyl-glucosamine (GlcNAc) to Ser and Cys residues of ThgA. The peptide derived from ThgA, which we name thermoglycocin, was structurally characterized and shown to resemble glycocin F. In addition to two nested disulfide bonds also present in glycocin F, thermoglycocin contains a third disulfide bond creating a C-terminal loop. Unexpectedly, ThgA lacks the common double glycine motif for leader peptide removal by a C39-peptidase. Based on AlphaFold3 modeling, we postulated that cleavage between the leader and core peptide would occur instead at a GK motif, which was experimentally confirmed for an orthologous BGC from Ornithinibacillus bavariensis. Its structurally similar product termed orniglycocin was also produced in E. coli and carries two GlcNAc moieties on two Cys residues. The C39 peptidase domain of the peptidase-containing ATP-binding cassette transporter (PCAT) from this BGC removed the leader peptide after a Gly-Lys motif and the orniglycocin so produced demonstrated antimicrobial activity. This study adds to the small number of characterized glycocins, employs AlphaFold3 to predict the leader peptide cleavage site, and suggests a common naming convention similar to that established for lanthipeptides. One-Sentence Summary: Thermoglycocin from Thermoanaerobacterium thermosaccharolyticum and orniglycocin from Ornithinibacillus bavariensis were produced heterologously in E. coli, shown to contain three disulfide bonds and two GlcNAcylations, and were released by a unique C39 protease that cleaves at a Gly-Lys sequence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.